Shares of enVVeno Medical Co. (NASDAQ:NVNOW – Get Rating) traded up 66.7% during trading on Monday . The company traded as high as $0.12 and last traded at $0.12. 6,189 shares traded hands during mid-day trading, a decline of 38% from the average session volume of 10,020 shares. The stock had previously closed at $0.07.
enVVeno Medical Trading Up 66.7 %
The company's fifty day moving average is $0.07 and its 200 day moving average is $0.11.
enVVeno Medical Company Profile
(Get Rating)
enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency.
Read More
- Get a free copy of the StockNews.com research report on enVVeno Medical (NVNOW)
- Go Where the Money Is. Here's 3 Top Bank Dividend Stocks to Buy
- Another Catalyst For Mullen Automotive Stock
- Solar Tech-Services; Nextracker Should Be On Your Radar
- Is American Lithium a Safe Bet as Demand for Lithium Soars
- Highwoods Properties, High-quality Real Estate for a Discount
Receive News & Ratings for enVVeno Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for enVVeno Medical and related companies with MarketBeat.com's FREE daily email newsletter.
